SCHEMBL6137813

SCHEMBL6137813

CCCCOc1ccc(C(=O)N(CCc2ccc(Cl)cc2)C(=N)N)cc1

nearest known ligand 0.50

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
PTGIR P43119 2/20 0.44
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8767719 0.73 CA1 (0.45) MAPT
SCHEMBL1283890 0.72 L3MBTL1 (0.61) MAPTTHRB
SCHEMBL1284112 0.72 L3MBTL1 (0.59) THRB
SCHEMBL9373815 0.72 MMP2 (0.50)
SCHEMBL4628766 0.71 NPC1 (0.61) MAPT
SCHEMBL6137598 0.71 DRD2 (0.53) MAPT
SCHEMBL4628771 0.70 SCN5A (0.70)
SCHEMBL18542248 0.70 TSHR (0.58) TP53MAPT
SCHEMBL6323761 0.70 L3MBTL1 (0.52) MAPTTHRBPTGIRMAOAMAOB
SCHEMBL6137840 0.69 SCN5A (0.49) TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP disclosed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP disclosed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO disclosed